186PPhase II trial of tepotinib vs sorafenib for...

Annals of Oncology 2018 / 11 Vol. 29; Iss. suppl_9

186PPhase II trial of tepotinib vs sorafenib for treatment-naïve advanced hepatocellular carcinoma (HCC) in Asian patients

Ryoo, B-Y, Ren, Z, Kim, T-Y, Pan, H, Rau, K-M, Choi, H J, Park, J-W, Kim, J H, Yen, C-J, Kim, B-H, Zhou, D, Straub, J, Zhao, C, Qin, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy432.038
Date:
November, 2018
File:
PDF, 100 KB
2018
Conversion to is in progress
Conversion to is failed